Secondary Hypertension: Differential Diagnosis and Basic Principles of Treatment

1. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 2014; 35(19):1245-54.Search in Google Scholar

2. Kallistratos MS, Giannakopoulos A, German V, Manolis AJ. Diagnostic Modalities of the Most Common Forms of Secondary Hypertension. Hellenic J Cardiol 2010; 51:518-29.Search in Google Scholar

3. Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: Why is it so resistant to treatment? Kidney Int 2006; 69(6):967-73.Search in Google Scholar

4. Campese VM. Pathophysiology of Resistant Hypertension in Chronic Kidney Disease. Semin Nephrol 2014; 34(5):571-6.10.1016/j.semnephrol.2014.08.01125416666Search in Google Scholar

5. Sugiura T, Nakamori A, Wada A, Fukahara Y. Evaluation of tubulointerstitial injury by Doppler ultrasonography in glomerular disease. Clin Nephrol 2004; 61(2):119-26.10.5414/CNP6111914989631Search in Google Scholar

6. Sarafidis PA, Bakris GL. Resistant Hypertension. J Am Col Cardiol 2008; 52(22):1749-57.10.1016/j.jacc.2008.08.03619022154Search in Google Scholar

7. Fagard RH. Resistant Hypertension. Heart 2012; 98(3):254-61.10.1136/heartjnl-2011-30074122199020Search in Google Scholar

8. Petrovic D. Renovaskularna hipertenzija: etiopatogeneza, dijagnostika i lecenje. U: Akutno oštecenje bubrega u klinickoj praksi. Petrovic D. Ed. Fakultet medicinskih nauka Univerziteta u Kragujevcu, Interprint 2012: 353-63.Search in Google Scholar

9. Baumgartner I, Lerman LO. Renovascular hypertension: screening and modern management. Eur Heart J 2011; 32(13):1590-8.10.1093/eurheartj/ehq510312829821273200Search in Google Scholar

10. Petrovic D. Renovaskularna hipertenzija: etiopatogeneza, dijagnostika i lecenje. U: Akutno oštecenje bubrega u klinickoj praksi. Petrovic D. Ed. Fakultet medicinskih nauka Univerziteta u Kragujevcu, Interprint 2012: 353-63.Search in Google Scholar

11. Slovut DP, Onlin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350(18):1862-71.10.1056/NEJMra03239315115832Search in Google Scholar

12. Sperati CJ, Aggarwal N, Arepally A, Atta MG. Fibromuscular dysplasia. Kidney Int 2009; 75(3):333-6.10.1038/ki.2008.23218528320Search in Google Scholar

13. Petrovic D. Vojinovic R, Lukic S, Novakovic B, Mijailovic M, Jagic N. Renovascular hypertension: diagnostic and therapy. Medicus 2005; 6(3):39-42.Search in Google Scholar

14. Clarkson MR, Magee CN, Brenner BM. Renovascular Hypertension and Ischemic Nephropathy. In: The Kidney. Clarkson MR, Magee CN, Brenner BM. Eds. Philadelphia: Oxford University Press 2010: 468-86.10.1016/B978-1-4160-6640-8.00023-3Search in Google Scholar

15. Radermacher J, Haller H. The right diagnostic workup: investigating renal and renovascular disorders. J Hypertens 2003; 21 (Suppl 2):19-24.10.1097/00004872-200305002-0000412929903Search in Google Scholar

16. Petrovic D, Novakovic B, Jagic N, Poskurica M, Stojimirovic B. Klinicki znacaj kolor dopler ultrasonografije u dijagnostikovanju renovaskularne hipertenzije. U: Kardionefrologija 4. Radenkovic S. Ed. Niš: GIP PUNTA 2009: 188-93.Search in Google Scholar

17. Granata A, Fiorini F, Andrulli S, Logias F, Galleni M, Romano G, Sicurezza E, Fiore CE. Doppler ultrasound and renal artery stenosis: An overview. J Ultrasound 2009; 12(4):133-43.10.1016/j.jus.2009.09.006356745623397022Search in Google Scholar

18. Gokhale S. Doppler Ultrasonography in Renovascular Hypertension. Ultrasound Clin 2010; 5(3):337-53.10.1016/j.cult.2010.07.002Search in Google Scholar

19. Petrovic D. Kontrastna nefropatija: etiopatogeneza, dijagnostika I lecenje. U: Akutno oštecenje bubrega u klinickoj praksi. Petrovic D. Ed. Fakultet medicinskih nauka Univerziteta u Kragujevcu, Interprint 2012: 373-88. Search in Google Scholar

20. Petrovic D. Nefrogena sistemska fibroza: etiopatogeneza, dijagnostika i lecenje. U: Akutno oštecenje bubrega u klinickoj praksi. Petrovic D. Ed. Fakultet medicinskih nauka Univerziteta u Kragujevcu, Interprint 2012: 389-95.Search in Google Scholar

21. Drieghe B, Madaric J, Sarno G, Manoharan G, Bartunek J, Heyndrickx GR, et al. Assessment of renal artery stenosis: side by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J 2008; 29(4):517-24.10.1093/eurheartj/ehm63118276621Search in Google Scholar

22. Romero CA, Orias M, Weir M. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol 2015; 11(4):242-52.10.1038/nrendo.2015.6709762225666495Search in Google Scholar

23. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, et al. Use of Doppler Ultrasonography to predict the outcome therapy for renal artery-stenosis. N Engl J Med 2001; 344(6):410-7.10.1056/NEJM20010208344060311172177Search in Google Scholar

24. Radermacher J. Echo-Doppler to predict the outcome for renal artery stenosis. J Nephrol 2002; 15(Suppl 6):69-76.Search in Google Scholar

25. Wiecek A, Chudek J, Adamczak M. Indications for renal revascularisation - the landscape after the ASTRAL study. Nephrol Dial Transplant 2010; 25(8):2399-402.10.1093/ndt/gfq12020501462Search in Google Scholar

26. Plouin PF, Bax L. Diagnosis and treatment of renal artery stenosis. Nat Rev Nephrol 2010; 6(3):151-9.10.1038/nrneph.2009.23020101256Search in Google Scholar

27. Mattsson C, Young WF. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Practice Nephrol 2006; 2(4):198-208. 10.1038/ncpneph015116932426Search in Google Scholar

28. Rossi GP. A comprehensive review of the clinical aspects of primary aldosteronism. Nat Rev Endocrinol 2011; 7(8):485-95.10.1038/nrendo.2011.7621610687Search in Google Scholar

29. Diederich S, Quinkler M, Morganti A, Bidlingmaier M. Endocirne Hypertension-Diagnosis and Treatment of Hormone-Induced Blood Pressure Disorders. Bremen: UNI-MED 2013: 12-87.Search in Google Scholar

30. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenze- Roquelpo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metabolism 2007; 3(2):92-102.10.1038/ncpendmet039617237836Search in Google Scholar

31. Pacak K. Preoperative Management of the Pheochromocytoma Patient. J Clin Endocrinol Metab 2007; 92(11):4069-79.10.1210/jc.2007-172017989126Search in Google Scholar

32. Cicala MV, Mantero F. Hypertension in Cushings Syndrome: from Pathogenesis to Treatment. Neuroendocrinology 2010; 92(Suppl 1):44-9.10.1159/00031431520829617Search in Google Scholar

33. Nieman LK, Biller BMK, Findling JW, Price JN, Savage MO, Stewart PM, Montori VM. The Diagnosis of Cushings Syndrome. An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93(5):1256-40.10.1210/jc.2008-0125238628118334580Search in Google Scholar

34. Raff H, Findling JW. A Physilogic Approach to Diagnosis of the Cushing Syndrome. Ann Intern Med 2003; 138(12):980-91.10.7326/0003-4819-138-12-200306170-0001012809455Search in Google Scholar

35. Raff H, Carroll T. Cushing,s syndrome: from physiological principles to diagnosis and clinical care. J Physiol 2015; 593(3):494-506.10.1113/jphysiol.2014.282871432470125480800Search in Google Scholar

36. Sica DA. Endocrine Causes of Secondary Hypertension. J Clin Hypertens 2008; 10(7):534-40. 10.1111/j.1751-7176.2008.08097.x811009118607139Search in Google Scholar